fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and.
.
international.
it would likely look like what occurred in minnesota last year, when a.
richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine..